Skip to content
From the American College of Rheumatology
Search for:
Toggle Navigation
Symptoms
Fever
Joint Pain
Muscle Pain and/or Weakness
Rashes
Raynaud’s Phenomenon
Diseases
ANCA-Associated Vasculitis
Behcet’s Syndrome
Crystalline Arthropathies
Drug and Medication-Induced Rheumatic Diseases
Giant Cell Arteritis
Henoch-Schönlein Purpura
IgG4-Related Disease
Juvenile Dermatomyositis
Juvenile Idiopathic Arthritis
Kawasaki Disease
Mixed Connective Tissue Disease
Multisystem Inflammatory Syndrome in Children
Myositis
Polyarteritis Nodosa
Polymyalgia Rheumatica
Rheumatoid Arthritis
Sarcoidosis
Sicca/Sjogren’s Disease
Spondyloarthritis
Systemic Lupus Erythematosus
Systemic Sclerosis
Case Studies
ANCA-Associated Vasculitis
Behcet’s Syndrome
Crystalline Arthropathies
Giant Cell Arteritis
Henoch-Schönlein Purpura
IgG4-Related Disease
Juvenile Dermatomyositis
Juvenile Inflammatory Arthritis
Kawasaki Disease
Mixed Connective Tissue Disease
Myositis
Pediatric Fevers
Polyarteritis Nodosa
Polymalgia Rheumatica
Raynaud’s Phenomenon
Rheumatoid Arthritis
Sarcoidosis
Sicca/Sjogren’s Disease
Spondyloarthritis
Systemic Lupus Erythematosus
Systemic Sclerosis
Labs
Meds
Commonly Used Rheumatology Meds
Treatment Considerations
Addressing Patient Fears About Rheumatology Medications
Medications by Diseases
Resources
Resources
Vaccination Considerations – Pediatrics
Vaccination Considerations – Adults
Glossary of Terms
ACR Clinical Guidelines
ACR Education Center
Rheumatology Provider Directory
cDMARD
Home
ยป
cDMARD
cDMARD
Conventional disease modifying anti-rheumatic drug
Primary Care
2024-03-27T23:53:20+00:00
Page load link
Go to Top
